24/7 Wall St. on MSN11h
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What's Next?
Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...
FiercePharma22h
Don't call it a comeback: Pfizer returns to Super Bowl with ad pledging to 'knock out' cancer
Last year marked the first time in Pfizer’s 175-year history that the drugmaker shelled out the requisite millions for ...
PBS16h
The U.S. dodged a bird flu pandemic nearly 70 years ago. Can we do it again?
By 1957, scientists had a significantly more sophisticated understanding of influenza, worrying them that a pandemic similar ...